Latest Breaking News On - Accelerate diagnostics - Page 5 : vimarsana.com

Equities Research Analysts New Coverage for April 4th (ABIO, ACOR, AEMD, AGRX, AHPI, AIRI, ALUR, ATHX, AXDX, AZTA)

Equities Research Analysts’ new coverage for Thursday, April 4th: StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD). They […]

United statesPiper sandlerSanfordc bernsteinRobertw bairdRaymond jamesJpmorgan chase coCantor fitzgeraldFlanigan enterprisesJefferies financial group incMorgan stanleyEquities research analystIndustries groupWells fargo companyNational western life groupInc dailyBiolife solutions

Accelerate Diagnostics, Inc (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.

United statesComunidad autonoma de catalunaJack phillipsWilliam blairAlex nowakDustin scaringeLaura piersonAndrew brackmannSecurities exchangeDiagnostics incAccelerate diagnosticsCall transcript marchAccelerate diagnostics fourth quarterFull yearSecurities actSecurities exchange act

Accelerate Diagnostics (NASDAQ:AXDX) PT Lowered to $1 00

Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) had its price target decreased by investment analysts at Craig Hallum from $2.00 to $1.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Craig Hallum’s price objective suggests a potential […]

United statesCraig hallumVanguard group incGriffin asset management incBaird financial group incDiagnostics incGeode capital managementAccelerate diagnosticsGet free reportFinancial groupStreet corpAsset managementCapital managementAccelerate phenoAccelerate diagnostics dailyNasdaq axdx

StockNews com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX)

Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 2.0 % Accelerate Diagnostics stock opened at $0.99 on Wednesday. The firm’s 50 day simple moving average is […]

United statesTejara capital ltdMorgan stanleyDiagnostics incBaird financial group incVanguard group incAccelerate diagnosticsGet free reportDiagnostics trading downCapital ltdFinancial groupTwo sigma investmentsAccelerate phenoAccelerate diagnostics dailyNasdaq axdxInitiated coverage

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Market newsStock adviceAccelerate diagnosticsAccelerate diagnostics missesMisses revenue